Indication
Major Salivary Gland Cancer
1 clinical trial
2 products
Clinical trial
Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Salivary Gland CancersStatus: Completed, Estimated PCD: 2022-11-05
Product
NivolumabProduct
Ipilimumab